EI
FULC icon

Ellevest Inc’s Fulcrum Therapeutics FULC Stock Holding History

Ellevest Inc’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19
Closed -$138 – 1968
2022
Q4 		$138 Sell
19
-20
-51% -$130 ﹤0.01% 1736
2022
Q3 		$0 Sell
39
-4
-9% -$29 ﹤0.01% 1688
2022
Q2 		$0 Buy
43
+19
+79% +$186 ﹤0.01% 1492
2022
Q1 		$1K Hold
24
– – ﹤0.01% 1288
2021
Q4 		$0 Buy
24
+20
+500% +$396 ﹤0.01% 1503
2021
Q3 		$0 Buy
+4
New +$76 ﹤0.01% 1468

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ellevest Inc's FULC Position: Q1 2023 in Review

Ellevest Inc sold out of Fulcrum Therapeutics (FULC) in Q1 2023, closing a stake of 19 shares — an estimated $138 sold.

Ellevest Inc first reported a position in FULC in Q3 2021 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 116 funds tracked by Wall St. Rank hold FULC as of Q1 2023.

  • Ellevest Inc reported no remaining Fulcrum Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Ellevest Inc sold 19 Fulcrum Therapeutics shares in Q1 2023, an estimated $138.
  • Ellevest Inc first reported a position in Fulcrum Therapeutics in Q3 2021 and held it in 6 quarters.
  • Ellevest Inc's Fulcrum Therapeutics position peaked at $1K in Q1 2022.
  • 116 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.